PT699076E - Vacina contra a otite media - Google Patents

Vacina contra a otite media

Info

Publication number
PT699076E
PT699076E PT94922428T PT94922428T PT699076E PT 699076 E PT699076 E PT 699076E PT 94922428 T PT94922428 T PT 94922428T PT 94922428 T PT94922428 T PT 94922428T PT 699076 E PT699076 E PT 699076E
Authority
PT
Portugal
Prior art keywords
fimbrin
media
otite
vaccine against
dna coding
Prior art date
Application number
PT94922428T
Other languages
English (en)
Inventor
Pappachan E Kolattukudy
Lauren O Bakaletz
Tatiana Sirakova
Original Assignee
Univ Ohio State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Ohio State Res Found filed Critical Univ Ohio State Res Found
Publication of PT699076E publication Critical patent/PT699076E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT94922428T 1993-05-18 1994-05-12 Vacina contra a otite media PT699076E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6544293A 1993-05-18 1993-05-18

Publications (1)

Publication Number Publication Date
PT699076E true PT699076E (pt) 2003-03-31

Family

ID=22062752

Family Applications (1)

Application Number Title Priority Date Filing Date
PT94922428T PT699076E (pt) 1993-05-18 1994-05-12 Vacina contra a otite media

Country Status (9)

Country Link
US (3) US5766608A (pt)
EP (2) EP1300156A3 (pt)
JP (1) JP3429313B2 (pt)
AT (1) ATE226831T1 (pt)
DE (1) DE69431624T2 (pt)
DK (1) DK0699076T3 (pt)
ES (1) ES2185658T3 (pt)
PT (1) PT699076E (pt)
WO (1) WO1994026304A1 (pt)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994026304A1 (en) 1993-05-18 1994-11-24 Ohio State Research Foundation Otitis media vaccine
EP1624068A1 (en) * 1993-06-01 2006-02-08 Life Technologies Inc. Genetic immunization with cationic lipids
US5770213A (en) 1994-05-05 1998-06-23 American Cyanamid Company Purified nontypable haemophilus influenzae P5 protein as a vaccine for nontypable haemophilus influenzae infection
US5843464A (en) 1995-06-02 1998-12-01 The Ohio State University Synthetic chimeric fimbrin peptides
GB9812613D0 (en) * 1998-06-11 1998-08-12 Smithkline Beecham Biolog Vaccine
EP1129064B1 (en) 1998-11-12 2008-01-09 Invitrogen Corporation Transfection reagents
EP1880735A3 (en) 1999-03-19 2008-03-12 GlaxoSmithKline Biologicals S.A. Vaccine
GB9918319D0 (en) 1999-08-03 1999-10-06 Smithkline Beecham Biolog Vaccine composition
GB0022742D0 (en) 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
GB0103171D0 (en) 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition
GB0117762D0 (en) * 2001-07-20 2001-09-12 Glaxosmithkline Biolog Sa Novel compounds
JP2006500963A (ja) 2002-08-02 2006-01-12 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ワクチン組成物
WO2004039417A2 (en) 2002-11-01 2004-05-13 Glaxosmithkline Biologicals S.A. Drying process
WO2005032584A2 (en) 2003-10-02 2005-04-14 Glaxosmithkline Biologicals S.A. Pertussis antigens and use thereof in vaccination
GB0505996D0 (en) 2005-03-23 2005-04-27 Glaxosmithkline Biolog Sa Fermentation process
CA2613970C (en) * 2005-07-08 2015-12-08 Children's Hospital, Inc. Chimeric vaccine for haemophilus influenzae-induced disease
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
AR058592A1 (es) 2005-12-22 2008-02-13 Glaxosmithkline Biolog Sa Vacuna
GB0607088D0 (en) 2006-04-07 2006-05-17 Glaxosmithkline Biolog Sa Vaccine
CA2636566C (en) 2006-01-17 2018-03-13 Arne Forsgren A novel surface exposed haemophilus influenzae protein (protein e; pe)
CN101883583B (zh) 2007-06-26 2017-05-17 葛兰素史密丝克莱恩生物有限公司 含有肺炎链球菌荚膜多糖缀合物的疫苗
WO2009103068A1 (en) 2008-02-15 2009-08-20 Life Technologies Corporation Methods and compositions for shearing of polymers by sonication
GB201003922D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Conjugation process
GB201003924D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Immunogenic composition
JP2013521770A (ja) 2010-03-10 2013-06-13 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ワクチン組成物
GB201103836D0 (en) 2011-03-07 2011-04-20 Glaxosmithkline Biolog Sa Conjugation process
US20130156803A1 (en) 2011-06-04 2013-06-20 Rochester General Hospital Research Institute Compositions and methods related to p6
CA2904388C (en) 2013-03-08 2023-09-26 Research Institute At Nationwide Children's Hospital Transcutaneous dosage formulation
WO2016011203A1 (en) 2014-07-15 2016-01-21 Life Technologies Corporation Compositions with lipid aggregates and methods for efficient delivery of molecules to cells
GB201518684D0 (en) 2015-10-21 2015-12-02 Glaxosmithkline Biolog Sa Vaccine
GB201621686D0 (en) 2016-12-20 2017-02-01 Glaxosmithkline Biologicals Sa Novel methods for inducing an immune response
IE87413B1 (en) 2017-05-30 2023-07-19 Glaxosmithkline Biologicals Sa Novel methods for manufacturing an adjuvant
MX2020005481A (es) 2017-12-01 2020-12-07 Glaxosmithkline Biologicals Sa Purificacion de saponina.
MX2021001479A (es) 2018-08-07 2021-04-28 Glaxosmithkline Biologicals Sa Novedosos procesos y vacunas.
EP3886901A1 (en) 2018-11-29 2021-10-06 GlaxoSmithKline Biologicals S.A. Methods for manufacturing an adjuvant
JP2022535091A (ja) 2019-06-05 2022-08-04 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム サポニン精製
GB202205833D0 (en) 2022-04-21 2022-06-08 Glaxosmithkline Biologicals Sa Bacteriophage
WO2024017827A1 (en) 2022-07-19 2024-01-25 Glaxosmithkline Biologicals Sa Continuous process for vaccine production

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888170A (en) * 1981-10-22 1989-12-19 Research Corporation Vaccines obtained from antigenic gene products of recombinant genes
DK219084D0 (da) * 1984-05-02 1984-05-02 Frederik Carl Peter Lindberg Antigen
US5110908A (en) * 1986-12-31 1992-05-05 Praxis Biologics, Inc. Haemophilus influenzae peptides and proteins
WO1994026304A1 (en) 1993-05-18 1994-11-24 Ohio State Research Foundation Otitis media vaccine

Also Published As

Publication number Publication date
DE69431624T2 (de) 2003-07-10
EP1300156A2 (en) 2003-04-09
EP0699076A4 (en) 1999-09-08
JP3429313B2 (ja) 2003-07-22
EP0699076A1 (en) 1996-03-06
US6562349B1 (en) 2003-05-13
JPH09500104A (ja) 1997-01-07
DK0699076T3 (da) 2003-03-03
US5766608A (en) 1998-06-16
ES2185658T3 (es) 2003-05-01
ATE226831T1 (de) 2002-11-15
US6030626A (en) 2000-02-29
DE69431624D1 (de) 2002-12-05
EP0699076B1 (en) 2002-10-30
WO1994026304A1 (en) 1994-11-24
EP1300156A3 (en) 2003-05-07

Similar Documents

Publication Publication Date Title
PT699076E (pt) Vacina contra a otite media
NO953033L (no) Stabile baktericid/permeabilitetsökende proteinprodukter og farmasöytiske preparater inneholdende disse
WO1999014341A3 (en) Proteases from gram-positive organisms
IL114809A0 (en) Mutant br96 antibodies
EP1446500A4 (en) PROCESS FOR REGULATING THE IMMUNE FUNCTION IN PRIMATES USING THE FOXP3 PROTEIN
CA2169854A1 (en) Enhanced expression in plants using non-translated leader sequences
EP1421195A4 (en) SURFACE EXPRESSION VECTORS WITH pgsBCA, THE GENE GENERATING POLY GAMMA GLUTAMATE SYNTHETASE, AND METHOD FOR EXPRESSING A TARGET PROTEIN ON THE SURFACE OF A MICROORGANISM USING THE VECTOR
ATE64619T1 (de) Menschliches apolipoprotein a1 sowie dessen variante, exprimiert in escherichia coli.
HU9502643D0 (en) Recombinant mersadicin and a method for production
AU8258591A (en) Human mk gene and protein sequence
HUP9800767A2 (hu) Kevésbé adszorbeálódó és jobban hidrolizáló szubtilizin DY variánsok
TW338069B (en) A kanamycin resistance gene derived from microorganisms of the genus rhodococcus
EP1251176A3 (en) Expression systems utilizing autolyzing fusion proteins and a reducing polypeptide
WO1995013386A3 (en) Tyrosinase-activator protein fusion enzyme
WO2001044289A3 (en) Modified leukotoxin gene and protein
WO2001075121A3 (en) 16836, a human phospholipase c family member and uses thereof
HU9600500D0 (en) Genes from actinoplanes sp. for biosynthesis of acarbose, process for their isolation and their use
MXPA01011563A (es) Una novedosa proteina 5 relacionada al factro-h y anticuerpos relacionados.
EP0288325A3 (en) Dna encoding isopenicillin n-synthetase from a.nidulans, its use and vectors encoding it.
AU5260801A (en) Novel (r)-2-hydroxy-3-phenylpropionate (d-phenyllactate) dehydrogenase and gene encoding the same
WO2002057457A3 (en) Human proteins 55562 and 21617, and methods of use thereof
WO2002026817A3 (en) 33521, a human guanine nucleotide exchange family member and uses thereof
DE59510916D1 (de) Verbessertes, induktionsfreies Verfahren zur Gentechnischen Herstellung von Glutarylamidase
KR960008410B1 (en) Gene and expression of mannose enzyme from corynebacterium glutamicum
EP1158052A4 (en) BETA-PRIMEVEROSIDASDE GENE